Barclays’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.4M | Buy |
292,047
+126,136
| +76% | +$3.63M | ﹤0.01% | 1252 |
|
|
2025
Q1 | $5.57M | Sell |
165,911
-16,030
| -9% | -$538K | ﹤0.01% | 1352 |
|
|
2024
Q4 | $9.3M | Sell |
181,941
-25,771
| -12% | -$1.32M | ﹤0.01% | 1167 |
|
|
2024
Q3 | $10.6M | Buy |
207,712
+89,358
| +76% | +$4.57M | ﹤0.01% | 1020 |
|
|
2024
Q2 | $5.3M | Buy |
118,354
+43,459
| +58% | +$1.95M | ﹤0.01% | 1140 |
|
|
2024
Q1 | $3.51M | Sell |
74,895
-116,089
| -61% | -$5.43M | ﹤0.01% | 1557 |
|
|
2023
Q4 | $6.8M | Buy |
190,984
+77,702
| +69% | +$2.76M | ﹤0.01% | 1290 |
|
|
2023
Q3 | $3.37M | Buy |
113,282
+21,189
| +23% | +$630K | ﹤0.01% | 1365 |
|
|
2023
Q2 | $1.66M | Sell |
92,093
-17,180
| -16% | -$309K | ﹤0.01% | 1856 |
|
|
2023
Q1 | $1.76M | Buy |
109,273
+40,430
| +59% | +$649K | ﹤0.01% | 1733 |
|
|
2022
Q4 | $1.26M | Buy |
68,843
+18,238
| +36% | +$334K | ﹤0.01% | 1966 |
|
|
2022
Q3 | $994K | Buy |
50,605
+46,563
| +1,152% | +$915K | ﹤0.01% | 2133 |
|
|
2022
Q2 | $75K | Sell |
4,042
-5,444
| -57% | -$101K | ﹤0.01% | 3582 |
|
|
2022
Q1 | $208K | Sell |
9,486
-48,301
| -84% | -$1.06M | ﹤0.01% | 3303 |
|
|
2021
Q4 | $1.64M | Buy |
57,787
+40,652
| +237% | +$1.16M | ﹤0.01% | 1911 |
|
|
2021
Q3 | $361K | Buy |
17,135
+2,074
| +14% | +$43.7K | ﹤0.01% | 2736 |
|
|
2021
Q2 | $283K | Sell |
15,061
-9,521
| -39% | -$179K | ﹤0.01% | 2750 |
|
|
2021
Q1 | $375K | Buy |
24,582
+13,674
| +125% | +$209K | ﹤0.01% | 2818 |
|
|
2020
Q4 | $153K | Sell |
10,908
-3,333
| -23% | -$46.8K | ﹤0.01% | 2821 |
|
|
2020
Q3 | $223K | Sell |
14,241
-2,547
| -15% | -$39.9K | ﹤0.01% | 2684 |
|
|
2020
Q2 | $295K | Buy |
16,788
+13,128
| +359% | +$231K | ﹤0.01% | 2613 |
|
|
2020
Q1 | $54K | Sell |
3,660
-7,538
| -67% | -$111K | ﹤0.01% | 3066 |
|
|
2019
Q4 | $281K | Buy |
11,198
+5,215
| +87% | +$131K | ﹤0.01% | 3008 |
|
|
2019
Q3 | $90K | Sell |
5,983
-2,650
| -31% | -$39.9K | ﹤0.01% | 3453 |
|
|
2019
Q2 | $216K | Buy |
8,633
+3,311
| +62% | +$82.8K | ﹤0.01% | 3154 |
|
|
2019
Q1 | $121K | Buy |
+5,322
| New | +$121K | ﹤0.01% | 3249 |
|
|
2018
Q4 | – | Sell |
-2,608
| Closed | -$75K | – | 4131 |
|
|
2018
Q3 | $75K | Buy |
+2,608
| New | +$75K | ﹤0.01% | 3567 |
|